Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1991-11-25
1993-08-10
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514685, 514925, A61K 3112, A61K 3122
Patent
active
052349519
ABSTRACT:
The present invention relates to an anti-ulcer agent comprising a compound represented by the following general formula I as the effective ingredient, and a novel chalcone derivative included in the compound represented by this general formula I: ##STR1## wherein X and Y independently stand for a hydrogen atom or together form a single bond, R.sub.1 stands for a hydroxyl group, an acetoxy group, a carboxymethoxy group or a methoxycarbonylmethoxy group, R.sub.2 stands for a hydrogen atom, an isoprenyl group, isopentyl group or a propyl group, R.sub.3 stands for a hydroxyl group or a methoxy group, R.sub.4 stands for a hydrogen atom, a hydroxyl group or a methoxy group, R.sub.5 stands for a hydrogen atom, a hydroxyl group, a methoxy group or an isopentyl group, R.sub.6 stands for a hydroxyl group, a methoxy group or a carboxymethoxy group, and R.sub.7 stands for a hydrogen atom or a methoxy group.
REFERENCES:
patent: 3137621 (1964-06-01), Lafon
patent: 3598840 (1971-08-01), Majoie
patent: 3686319 (1972-08-01), Lafon
patent: 3743716 (1973-07-01), Rizzi et al.
patent: 4279930 (1981-07-01), Hall et al.
patent: 4605674 (1986-08-01), Fujiu et al.
patent: 5106871 (1992-04-01), Komazawa et al.
Komatsu et al., "Studies on the Constituents of Sophora Species I. Constituents of Sophora subprostrata, Chun et T. Chen.(I). Isolation and Structure of New Flavonoids, Sophoradin and Sophoranone.sup.1) ", Chem. Pharm. Bull., vol. 18. No. 3, pp. 602-607 (1970).
Kyogoku et al., "Synthesis of Isoprenyl Chalcone `Sophoradin` through Claise Rearrangement", Agr. Biol. Chem., vol. 39, No. 3, pp. 667-672 (1975).
Kyogoku et al., "Anti-ulcer Effect of Isoprenyl Flavonoids. II..sup.1) Synthesis and Anti-ulcer Activity of New Chalcones Related to Sophoradin", Chem. Pharm. Bull., vol. 27, No. 12, (1979), pp. 2943-2953.
Kyogo et al., "Isoprenylchalcones", Chemical Abstracts, vol. 85, No. 1, Abstract No. 5913q (Jul. 5, 1976), p. 478.
Miyazaki, "Antiulcer Agents in Licorice", Chemical Abstracts, vol. 80, No. 8, Abstract No. 41034j, (Feb. 25, 1974), p. 269.
Kyogoku et al., "Isoprenylchalcones", Chemical Abstracts, vol. 83, No. 21, Abstract No. 178567s, (Nov. 24, 1975), p. 528.
"Dihydrochalcone Derivative", Patent Abstracts of Japan, vol. 4, No. 98, (1980), p. 580.
Hatayama et al., "Anti-ulcer Effect of Isoprenyl Flavonoids. III..sup.1) Synthesis and Anti-ulcer Activity of Metabolites of 2'-Carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone.sup.2) ", Chem. Pharm. Bull., vol. 33, No. 4, (Apr. 1985).
"Chalcone Derivatives", Patent Abstracts of Japan, vol. 3, No. 46, (Apr. 18, 1979), p. 19.
Chem. Pharm. Bull., 18, pp. 602-607 (1970).
Agr. Biol. Chem., 39, pp. 667-672 (1975).
Hosaka Kunio
Komazawa Yukio
Mitsuhashi Hiroshi
Takeda Shigefumi
Watanabe Toshihiko
Schenkman Leonard
Tsumura Juntendo Inc.
LandOfFree
Anti-ulcer agent comprising chalcone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-ulcer agent comprising chalcone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-ulcer agent comprising chalcone derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1725542